Chytil F
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
Eur J Clin Nutr. 1996 Jul;50 Suppl 3:S21-3.
To review longstanding experience in the safe use of vitamin A as therapeutic agent in prematurely born human neonates and more recently with young children infected with the respiratory syncytial virus (RSV).
The studies reviewed were designed to intervene with vitamin A in the form of retinyl palmitate in human neonates and infants showing low levels of retinol in the blood.
Vanderbilt University School of Medicine.
Evidence is presented that vitamin A can be administered safely to human neonates and infants without apparent acute toxic effects.
A carefully designed mode of administration of vitamin A can improve a patient's vitamin A status as determined by the elevation of blood vitamin A levels which in turn may be beneficial in lowering the morbidity.
回顾长期以来将维生素A作为治疗药物安全用于早产新生儿以及近期用于感染呼吸道合胞病毒（RSV）的幼儿的经验。
所回顾的研究旨在对血液中视黄醇水平较低的人类新生儿和婴儿给予棕榈酸视黄酯形式的维生素A进行干预。
范德比尔特大学医学院。
有证据表明，维生素A可安全用于人类新生儿和婴儿，且无明显急性毒性作用。
精心设计的维生素A给药方式可通过提高血液维生素A水平来改善患者的维生素A状态，这反过来可能有助于降低发病率。
